CARDIFF ONCOLOGY, INC. Shares Outstanding (Cover Page)
CARDIFF ONCOLOGY, INC. (CRDF) had Shares Outstanding (Cover Page) of 77.80 million shares as of 2026-08-06, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-06: Entity Common Stock, Shares Outstanding 77.80M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 68.37M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 68.36M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 67.36M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 77.80M shares 10-Q · filed 2026-08-11 |
| 2026-04-30 | 68.37M shares 10-Q · filed 2026-05-14 |
| 2026-02-19 | 68.36M shares 10-K · filed 2026-02-24 |
| 2025-10-30 | 67.36M shares 10-Q · filed 2025-11-06 |
| 2025-07-24 | 66.53M shares 10-Q · filed 2025-07-29 |
| 2025-05-01 | 66.53M shares 10-Q · filed 2025-05-08 |
| 2025-02-20 | 66.52M shares 10-K · filed 2025-02-27 |
| 2024-11-04 | 51.13M shares 10-Q · filed 2024-11-07 |
| 2024-08-06 | 46.55M shares 10-Q · filed 2024-08-08 |
| 2024-04-25 | 44.72M shares 10-Q · filed 2024-05-02 |
| 2024-02-22 | 44.68M shares 10-K · filed 2024-02-29 |
| 2023-10-26 | 44.68M shares 10-Q · filed 2023-11-02 |
| 2023-08-03 | 44.68M shares 10-Q · filed 2023-08-09 |
| 2023-04-27 | 44.68M shares 10-Q · filed 2023-05-04 |
| 2023-02-23 | 44.68M shares 10-K · filed 2023-03-02 |
| 2022-10-27 | 44.68M shares 10-Q · filed 2022-11-03 |
| 2022-07-28 | 43.33M shares 10-Q · filed 2022-08-04 |
| 2022-04-28 | 43.31M shares 10-Q · filed 2022-05-05 |
| 2022-02-17 | 43.31M shares 10-K · filed 2022-02-24 |
| 2021-10-29 | 39.55M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 39.55M shares 10-Q · filed 2021-08-05 |
| 2021-04-29 | 37.55M shares 10-Q · filed 2021-05-06 |
| 2021-02-18 | 37.05M shares 10-K · filed 2021-02-25 |
| 2020-10-30 | 35.32M shares 10-Q · filed 2020-11-05 |
| 2020-08-06 | 23.23M shares 10-Q · filed 2020-08-11 |
| 2020-04-30 | 12.30M shares 10-Q · filed 2020-05-07 |
| 2020-02-20 | 10.21M shares 10-K · filed 2020-02-27 |
| 2019-10-31 | 7.74M shares 10-Q · filed 2019-11-07 |
| 2019-07-31 | 5.45M shares 10-Q · filed 2019-08-08 |
| 2019-04-30 | 5.25M shares 10-Q · filed 2019-05-07 |
| 2019-02-15 | 4.02M shares 10-K · filed 2019-03-06 |
| 2018-10-31 | 22.99M shares 10-Q · filed 2018-11-07 |
| 2018-07-31 | 17.69M shares 10-Q · filed 2018-08-03 |
| 2018-04-30 | 59.38M shares 10-Q · filed 2018-05-08 |
| 2018-02-12 | 55.29M shares 10-K · filed 2018-02-26 |
| 2017-10-31 | 38.11M shares 10-Q · filed 2017-11-09 |
| 2017-07-31 | 37.27M shares 10-Q · filed 2017-08-09 |
| 2017-04-28 | 30.97M shares 10-Q · filed 2017-05-10 |
| 2017-02-28 | 30.96M shares 10-K · filed 2017-03-15 |
| 2016-10-31 | 30.62M shares 10-Q · filed 2016-11-09 |
| 2016-07-31 | 30.15M shares 10-Q · filed 2016-08-04 |
| 2016-04-29 | 29.86M shares 10-Q · filed 2016-05-10 |
| 2016-02-29 | 29.76M shares 10-K · filed 2016-03-10 |
| 2015-10-30 | 29.72M shares 10-Q · filed 2015-11-09 |
| 2015-07-31 | 29.62M shares 10-Q · filed 2015-08-10 |
| 2015-04-30 | 24.46M shares 10-Q · filed 2015-05-05 |
| 2015-02-27 | 24.12M shares 10-K · filed 2015-03-12 |
| 2014-10-31 | 18.90M shares 10-Q · filed 2014-11-06 |
| 2014-08-05 | 18.90M shares 10-Q · filed 2014-08-07 |
| 2014-05-09 | 18.90M shares 10-Q · filed 2014-05-12 |
| 2014-03-13 | 18.90M shares 10-K · filed 2014-03-17 |
| 2013-11-08 | 18.90M shares 10-Q · filed 2013-11-14 |
| 2013-08-09 | 18.85M shares 10-Q · filed 2013-08-14 |
| 2013-05-09 | 15.62M shares 10-Q · filed 2013-05-14 |
| 2013-03-22 | 15.60M shares 10-K · filed 2013-04-01 |
| 2012-11-09 | 14.18M shares 10-Q · filed 2012-11-14 |
| 2012-08-09 | 14.18M shares 10-Q · filed 2012-08-14 |
| 2012-05-14 | 69.18M shares 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |